期刊
BIOMATERIALS
卷 152, 期 -, 页码 15-23出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2017.10.032
关键词
Near-infrared persistent luminescence; Photoluminescence; Multimodal imaging; Cancer therapy
资金
- Bureau of International Cooperation, the Chinese Academy of Sciences [132C35KYSB20160021]
- National Natural Science Foundation of China [21507129, 61705228]
- Program of International Cooperation of Xiamen [3502Z20161248]
- Shuang Bai Plan of Fujian Province
Multifunctional nanoplatforms with multimodal imaging and cancer therapy capabilities have attracted attention in biomedical applications. Near-infrared persistent luminescence nanoparticles (NPLNPs) were considered one of the most promising candidates for constructing multifunctional nanoplatforms due to the absence of in situ excitation and high signal-to-noise ratios (SNRs). Here, we report a novel NPLNP mSiO(2)@Gd(3)GasO(12):Cr3+, Nd3+ (mSiO(2)@GGO) as multifunctional nanoplatforms for multimodal imaging and cancer therapy. These NPs exhibited a persistent luminescence (745 nm) of more than 3 h in the first near-infrared window (NIR-I) after UV excitation, which can realize high SNRs and long-term in vivo imaging. Moreover, these NPs showed excellent NIR luminescence (1067 nm) in the second near-infrared window (NIR-II) under 808 nm excitation, which is more suitable for deep tissue imaging due to the lower photon scattering and deeper tissue penetration of NIR-II luminescence. Furthermore, the host Gd3Ga5O12 with high Gd3+ concentration showed a high r(1) value (10.70 mM(-1) s(-1)) and was suitable for T-1 MR imaging. The mesoporous silica nanoparticles (mSiO(2)) served as a framework to control the mSiO(2)@GGO particle morphology and provide low toxicity and drug loading capacity for cancer therapy. (C) 2017 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据